Arena Pharmaceuticals Stock News

Pfizer Inc (NYSE: PFE) executed a definitive agreement with Arena Pharmaceuticals (Nasdaq: ARNA), under which Pfizer Inc will acquire Arena Pharmaceutical for a total equity value of around $6.7 bi

Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The SP also fell, dropping 0.46% to 4,690.48. The U.S. has the highest number of

Equity index futures are pointing slightly higher on Monday morning as investors appear to be a little tentative ahead of the Fed meeting later this week. Friday’s Consumer Price Index (CPI) shouldn

Pfizer has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline.

Pfizer is spending $6.7 billion to buy a drugmaker with no products on the market and a focus on developing treatments for inflammatory conditions like Chrohns disease

US drugmaker Pfizer today announced it has reached a $6.7bn deal to acquire Arena Pharmaceuticals, a company developing treatments for several US drugmaker Pfizer today announced it has reached a $6.7bn deal to acquire Arena Pharmaceuticals, a company developing treatments for several immuno-inflammatory diseases.

Stocks looked poised to rise again Monday morning.

Pfizer Inc will buy drug developer Arena Pharmaceuticals for $6.7 billion in cash, to add a promising treatment candidate that targets diseases affecting the stomach and intestine

Pfizer Inc. said Monday it has agreed to acquire Arena Pharmaceuticals Inc. in a deal with a value of about $6.7 billion, sending both stocks sharply higher.

With billions in war chest from sales of covid vaccines, pharma giant Pfizer announced on Monday it has agreed to rival drugmaker Arena Pharmaceuticals Pfizer for $6.7 billion cash or $100 per share. Pfizer said it expects to finance the transaction with existing cash [] The post Pfizer buys rival drugmaker Arena Pharmaceuticals for $6.7 billion cash appeared first on Tech News | Startups News .

BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Monday''s pre-market trading (as of 07.10 A.M. ET).In the Green Arena Pharmaceuticals, Inc. (ARNA) is up over 97% at $9

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Arena Pharmaceuticals, Inc. (ARNA) have entered into a definitive agreement under which Pfizer will acquire Arena. Pfizer will acquire all the outst…

Our call of the day from Stifel sees the Fed working toward a bubble of the century. Here's what happened before.